+48.2%
GSK vs CBOE
+136.7%
-88.5%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | CBOE | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | -2.2% | +2.3% | +0.3% |
| 7D | -3.5% | -5.8% | +2.3% | -2.8% |
| 30D | -3.4% | -3.1% | -0.3% | -3.1% |
| 3M | -8.1% | -4.8% | -3.4% | -7.7% |
| 6M | -11.1% | -0.6% | -10.6% | -11.9% |
| YTD | +0.7% | +12.8% | -12.1% | -2.6% |
| 1Y | +20.1% | +19.8% | +0.4% | +14.5% |
| 3Y | +46.1% | +86.9% | -40.8% | +24.9% |
| All | +48.2% | +136.7% | -88.5% | +16.4% |
Cumulative growth
Daily Returns
Daily percentage return beside CBOE.
Daily Out/Under-Performance
Portfolio return minus CBOE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CBOE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded CBOE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling